Full name
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
TAX ID1182216403
Rate company:
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1182216403
KRS0000870572
Share capital5,000.00 zł
address
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1182216403
REGON
387621050
KRS
0000870572
Legal form
limited liability company
Register Address
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
Date of registration in KRS
2020-11-25
Date of commencement of economic activity
2020-11-25
Act signature
WA.XII NS-REJ.KRS/37555/25/650
Pkd codes
72.10.Z - Scientific research and development in natural and technical sciences
01.28.Z - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
71.20.A - Food quality testing and analysis
71.20.C - Other technical testing and analysis
72.10 - Scientific research and development in natural and technical sciences
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Profit (loss) on sale  | -10,7 | -11,8 | -10,5 |
Gross profit (loss) | -1,2 | -11,9 | -861,8 |
EBITDA | -1,2 | -11,9 | -870,7 |
Short time liabilities | 6,3 | 23,9 | 277,8 |
Other operating costs | 0 | 0 | 34,5 |
Equity capital | 3,8 | -8,1 | -315,3 |
Operating profit (EBIT) | -1,2 | -11,9 | -870,7 |
Assets | 10,1 | 15,8 | 56,6 |
Net profit (loss) | -1,2 | -11,9 | -861,8 |
Cash | 9,1 | 13,4 | 47,1 |
Net income from sale | 123,5 | 141,5 | 14,6 |
Liabilities and provisions for liabilities | 6,3 | 23,9 | 277,8 |
Working assets | 9,1 | 14,8 | 62,9 |
Other income costs | 9,5 | 0 | -100 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -32,8 | 146,4 | 179,2 |
Equity capital to total assets | 37,3 | -51,3 | -88,6 |
Gross profit margin | -1 | -8,4 | -7,4 |
EBITDA Margin | -1 | -8,4 | -7,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 19 | 62 | 43 |
Current financial liquidity indicator | 1.4367784261703491 | 0.6192831993103027 | -0,8 |
Net dept to EBITDA | 7.441469669342041 | 1.127572774887085 | -6,3 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download xlsx01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
ClinScope Bogna Majewska
Bydgoszcz
JACEK HUNICZ SENSYCONTROL
Lublin
EDWARD KULIKOWSKI ARTAGRO
Kraków
PaperAccepted.net
WARSZAWA
PCS Sp. z o.o.
Toruń